{
  "author": {
    "name": "Isis Almeida",
    "webUrl": "/author/profile/isis-almeida/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2020/04/21/what-to-disclose-about-covid-19-infections/",
        "title": "What to Disclose About Covid-19 Infections",
        "byline": "Bob Van Voris & Isis Almeida",
        "kicker": "Q&A",
        "prettyDate": "April 21, 2020",
        "timeToRead": "3 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/bob-van-voris/",
            "name": "Bob Van Voris"
          },
          {
            "webUrl": "/author/profile/isis-almeida/",
            "name": "Isis Almeida"
          }
        ],
        "kickerNode": [
          {
            "uri": "/q-and-a/",
            "sectionName": "Q&A"
          }
        ],
        "summary": "A Q&A on how companies should manage decisions about public (and internal) disclosures when an employee or executive receives a positive diagnosis.",
        "body": null
      }
    ]
  }
}